
Theriva (TOVX) Gains Traction In Pre-Market Following Trial Update
Theriva Biologics, Inc. (NYSE: TOVX) shares are significantly gaining traction on the charts during pre-market session today, up 62.5% to $2.21 as of the last
Home » Morning News
Theriva Biologics, Inc. (NYSE: TOVX) shares are significantly gaining traction on the charts during pre-market session today, up 62.5% to $2.21 as of the last
Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares were increasing notably after a major regulatory development. Its shares jumped 5.62% in pre-market trading to $17.10. The
PMGC Holdings Inc. (NASDAQ: ELAB) shares continue their upward momentum, showing a significant pre-market surge. As of the most recent pre-market session, ELAB stock rose
After the announcement of its third-quarter financial data, Seagate Technology Holdings plc (NASDAQ: STX) saw a significant increase in share price. As of the last
The revelation of encouraging preclinical data caused Portage Biotech Inc.’s (NASDAQ: PRTG) stock price to spike higher. PRTG shares were trading at $12.90 as of
Following a significant deployment deal that strengthens its position in military production, shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) are continuing their upward trend in
The market observed a sharp increase in Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares after the company revealed a noteworthy intellectual property milestone. The stock of
Adagio Medical Holdings, Inc. (NASDAQ: ADGM) stock has increased significantly in the wake of a significant regulatory development. As of the most recent check, ADGM
Pre-market trading saw a sharp increase in the price of iCAD, Inc.’s (NASDAQ: ICAD) shares, which rose 69.37% to $3.27. The news of a major
After a major regulatory development, Verve Therapeutics, Inc. (NASDAQ: VERV) shares enjoyed a notable surge. The news that the U.S. Food and Drug Administration (FDA)
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.